| B4galnt1 |
Mus musculus |
|
B4galnt1 is differentially expressed in 112 experiments [118 up/106 dn]: 50 organism parts: liver [12 up/2 dn], hippocampus [9 up/0 dn], ...; 5 disease states: normal [0 up/2 dn], lung adenocarcinoma [1 up/0 dn], ...; 20 cell types, 2 cell lines, 19 compound treatments and 10 other conditions. |
| B4galnt1, Galgt, Galgt1, Ggm2 |
|
B4GALNT1 (Homo sapiens)
B4GN1_RAT (Rattus norvegicus)
(Compare orthologs)
|
|
|
| Ganglioside GM2 synthase, Glycosyl transferase, family 2 |
|
|
| (N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity, ganglioside biosynthetic process, integral to Golgi membrane, lipid storage, transferase activity, transferring hexosyl groups |
|
|
|
Q09200
Q3UN35
Q8VDF0
|
|
|
|
ENSMUSG00000006731
|
|
|
| Factor Value |
Factor |
Up/Down |
Legend: - number of studies the gene is up/down in
|
|
Liver
|
Organism part |
|
|
Wild_type
|
Genotype |
|
|
Hippocampus
|
Organism part |
|
|
Kidney
|
Organism part |
|
|
Control
|
Compound treatment |
|
|
Spleen
|
Organism part |
|
|
Amygdala
|
Organism part |
|
|
Pituitary gland
|
Organism part |
|
|
Jejunum
|
Organism part |
|
|
Hypothalamus
|
Organism part |
|
|
Colon
|
Organism part |
|
|
Cerebellum
|
Organism part |
|
|
Hematopoietic stem cell
|
Cell type |
|
|
Skeletal muscle
|
Organism part |
|
|
Retina
|
Organism part |
|
|
Normal
|
Disease state |
|
|
C57BL/6J
|
Strain or line |
|
|
Testis
|
Organism part |
|
|
E13.5
|
Developmental stage |
|
|
E15.5
|
Developmental stage |
|
|
E14.5
|
Developmental stage |
|
|
Embryonic stem cell
|
Cell type |
|
|
Mdx
|
Genotype |
|
|
None
|
Compound treatment |
|
|
Control
|
Infection |
|
|
Mycobacterium tuberculosis
|
Infection |
|
|
Brown adipose tissue
|
Organism part |
|
|
Heart
|
Organism part |
|
|
White adipose tissue
|
Organism part |
|
|
Choroid plexus fourth ventricl...
|
Organism part |
|
|
Ileum
|
Organism part |
|
|
Adrenal gland
|
Organism part |
|
|
Motor cortex
|
Organism part |
|
|
Cingulate cortex
|
Organism part |
|
|
Striatum
|
Organism part |
|
|
Cerebral cortex
|
Organism part |
|
|
Quadriceps skeletal muscle
|
Organism part |
|
|
Quadriceps muscle
|
Organism part |
|
|
Anterior tibialis
|
Organism part |
|
|
Th1
|
Cell type |
|
|
Th2
|
Cell type |
|
|
Dentate gyrus
|
Organism part |
|
|
Perirhinal cortex
|
Organism part |
|
|
Lung adenocarcinoma
|
Disease state |
|
|
Lung
|
Organism part |
|
|
Tristetrapolin-deficient
|
Genotype |
|
|
CBA/CaJ
|
Strain or line |
|
|
Lipopolysaccharide
|
Compound treatment |
|
|
Pancreatic islet
|
Organism part |
|
|
Pkd1 -/-
|
Genotype |
|
|
Hippocampus CA3
|
Organism part |
|
|
Bed nucleus of the stria termi...
|
Organism part |
|
|
Dinitrofluorobenzene
|
Compound treatment |
|
|
Muscle
|
Organism part |
|
|
Bone marrow
|
Organism part |
|
|
E16.5
|
Developmental stage |
|
|
Entorhinal cortex
|
Organism part |
|
|
Forebrain
|
Organism part |
|
|
8-cell
|
Developmental stage |
|
|
Trans-10, cis-12 conjugated li...
|
Compound treatment |
|
|
Pam3CSK4
|
Compound treatment |
|
|
Soleus muscle
|
Organism part |
|
|
Interleukin-2
|
Compound treatment |
|
|
Periaqueductal grey
|
Organism part |
|
|
Pancreas
|
Organism part |
|
|
Partial hepatectomy
|
Injury |
|
|
Adult
|
Developmental stage |
|
|
Embryo
|
Developmental stage |
|
|
PKB alpha null
|
Genotype |
|
|
Dibenzazepine
|
Compound treatment |
|
|
Neural
|
Observation |
|
|
Non-neural
|
Observation |
|
|
Vehicle - arachis oil
|
Compound treatment |
|
|
Hippocampus CA1
|
Organism part |
|
|
Bmal1-/-
|
Genotype |
|
|
E12.5
|
Developmental stage |
|
|
SCA1 knock-in
|
Genotype |
|
|
IL-21
|
Compound treatment |
|
|
Megakaryocyte
|
Cell type |
|
|
Megakaryocyte progenitor
|
Cell type |
|
|
White preadipocyte
|
Cell type |
|
|
Brown preadipocyte
|
Cell type |
|
|
Microglial cell
|
Cell type |
|
|
4T1
|
Cell line |
|
|
CD25-CD44-CD4+CD8- (4)
|
Phenotype |
|
|
Ovary
|
Organism part |
|
|
Wild_type
|
Strain or line |
|
|
BALB/c SCID
|
Strain or line |
|
|
Cardiotoxin
|
Compound treatment |
|
|
Neural stem/progenitor cell
|
Cell type |
|
|
Breast cancer
|
Disease state |
|
|
Myeloid progenitor cell
|
Cell type |
|
|
Early (24 to 26 weeks)
|
Disease staging |
|
|
ATF3(-/-)
|
Genotype |
|
|
Constant darkness
|
Light |
|
|
12 h light:12 h dark
|
Light |
|
|
SCA7 knock-in
|
Genotype |
|
|
Blastocyst
|
Developmental stage |
|
|
IL-15 and IL-21
|
Compound treatment |
|
|
Medial gastrocnemius
|
Organism part |
|
|
Late (42 weeks)
|
Disease staging |
|
|
Primary dermal fibroblast
|
Cell type |
|
|
Puberty
|
Developmental stage |
|
|
Genistein
|
Compound treatment |
|
|
BALB/c
|
Strain or line |
|
|
Uninfected
|
Infection |
|
|
Plasmodium chabaudi
|
Infection |
|
|
Post-puberty
|
Developmental stage |
|
|
Mature B cell
|
Cell type |
|
|
E18.5
|
Developmental stage |
|
|
Gata-1(-/-)
|
Genotype |
|
|
N-(1-naphthyl)ethylenediamine ...
|
Compound treatment |
|
|
P16
|
Developmental stage |
|
|
E18
|
Developmental stage |
|
|
Nix null mutant
|
Genotype |
|
|
P0
|
Developmental stage |
|
|
Multiple myeloma tumour cell
|
Cell type |
|
|
B220+ B cell
|
Cell type |
|
|
Monoclonal gammopathy of undet...
|
Disease state |
|
|
Multiple myeloma
|
Disease state |
|
|
Human chorionic gonadotrophin
|
Compound treatment |
|
|
Intermediolateral column moton...
|
Cell type |
|
|
Tcf1-/-
|
Genotype |
|
|
67NR
|
Cell line |
|
|
Neonate
|
Developmental stage |
|
|
Fetus
|
Developmental stage |
|
|
Primary osteoblast
|
Cell type |
|
|
B220hi sIgM+
|
Phenotype |
|
|
T effector cell
|
Cell type |
|
|
Hippocampus CA8
|
Organism part |
|
|
Rostral to trauma
|
Observation |
|
|
Dorsal root ganglion
|
Organism part |
|
|
Spinal cord
|
Organism part |
|
|
SCA7 wild_type
|
Genotype |
|
|
Brain
|
Organism part |
|
|
P112
|
Developmental stage |
|
|
No symptoms
|
Clinical info |
|
|
Allergen
|
Compound treatment |
|
|
Control - PBS
|
Compound treatment |
|
|
Lacrimal gland
|
Organism part |
|
|
T8 spindal segment
|
Organism part |
|
|
Cytarabine sensitive
|
Phenotype |
|
|
Cytarabine resistant
|
Phenotype |
|
|
Ara-C
|
Compound treatment |
|
|
Interferon-gamma
|
Compound treatment |
|
|
Site of trauma
|
Observation |
|
|
FVB/NJ
|
Strain or line |
|
|
Glutamatergic neuron
|
Cell type |
|
|
R6/1 transgenic
|
Genotype |
|
|
Extraocular muscle
|
Organism part |
|
|
Gastrocnemius and soleus muscl...
|
Organism part |
|
|
Epiblast
|
Cell type |
|
|
|
|
|
Processing time: 0.129 secs.